On the other hand, the Ras signaling molecule has been shown to be mutated/activated in cancer, including NSCLC, leading to the subsequent activation of Erk1/2 and resulting in cell proliferation and resistance to chemotherapy and radiation [71]. The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.